Stockscreener 앱 받기
18.78
3.40%
-0.66
시간 외 거래:
18.78
전일 마감가:
$19.44
열려 있는:
$18.9
하루 거래량:
384.87K
Relative Volume:
1.05
시가총액:
$348.65M
수익:
$62.81M
순이익/손실:
$-13.75M
주가수익비율:
-23.48
EPS:
-0.8
순현금흐름:
$153.00K
1주 성능:
-10.74%
1개월 성능:
+0.16%
6개월 성능:
+86.87%
1년 성능:
+260.46%
1일 변동 폭
$18.24
$19.43
1주일 범위
$18.24
$21.56
52주 변동 폭
$3.78
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
명칭
Optimizerx Corp
전화
248-651-6558
주소
260 CHARLES STREET, WALTHAM, MI
OPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
18.78 | 360.90M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
293.49 | 47.98B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
84.49 | 15.41B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
65.82 | 12.54B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.03 | 8.17B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.49 | 7.08B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2024-04-04 | 개시 | JMP Securities | Mkt Outperform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-02-02 | 재개 | B. Riley Securities | Buy |
| 2022-11-01 | 개시 | Stifel | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2021-10-18 | 재개 | B. Riley Securities | Buy |
| 2021-04-13 | 개시 | RBC Capital Mkts | Outperform |
| 2019-01-03 | 개시 | William Blair | Outperform |
모두보기
Optimizerx Corp 주식(OPRX)의 최신 뉴스
Will OptimizeRx Corporation stock maintain momentum in 2025New Guidance & Safe Entry Momentum Tips - newser.com
[Form 4] OptimizeRx Corp Insider Trading Activity - Stock Titan
Can a trend reversal in OptimizeRx Corporation lead to recoveryEarnings Risk Summary & Long-Term Safe Return Strategies - newser.com
Will OptimizeRx Corporation stock recover faster than market2025 Volume Leaders & Daily Price Action Insights - newser.com
What analyst consensus says on OptimizeRx Corporation stockMarket Risk Analysis & Long-Term Safe Investment Ideas - newser.com
Is now a turning point for OptimizeRx CorporationQuarterly Trade Report & AI Forecasted Entry and Exit Points - newser.com
Will OptimizeRx Corporation stock deliver better than expected guidanceWeekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com
Why OptimizeRx Corporation stock appeals to analysts2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com
Can OptimizeRx Corporation stock attract ESG capital inflows2025 Technical Patterns & Technical Confirmation Alerts - newser.com
OptimizeRx Corporation (OPRX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
OptimizeRx (OPRX) to Release Earnings on Thursday - MarketBeat
OptimizeRx Corporation stock chart pattern explained2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Why OptimizeRx Corporation stock attracts global investorsMarket Performance Report & Verified Stock Trade Ideas - newser.com
OptimizeRx (NASDAQ: OPRX) sets Q2 results call Aug 7 via webcast and dial-in access - Stock Titan
OptimizeRx Corp. Hits New 52-Week High of $21.99, Up 90% Yearly - Markets Mojo
OptimizeRx Corporation stock outlook for YEARWeekly Earnings Recap & Long-Term Investment Growth Plans - newser.com
What insider trading reveals about OptimizeRx Corporation stockPortfolio Value Report & Capital Efficient Trade Techniques - Fundação Cultural do Pará
Aug Outlook: Why OptimizeRx Corporation stock appeals to analystsJobs Report & Free Safe Capital Growth Stock Tips - fcp.pa.gov.br
Is OptimizeRx Corporation stock in correction or buying zoneGold Moves & Daily Volume Surge Trade Alerts - Fundação Cultural do Pará
Why analysts upgrade OptimizeRx Corporation stockEarnings Overview Summary & Safe Capital Preservation Plans - fcp.pa.gov.br
Is OptimizeRx Corporation stock recession proofJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat
RBC Capital Downgrades OptimizeRx (OPRX) - MSN
OptimizeRx Stock Delivers Over 90% Gain In Six MonthsA Prescription For Portfolio Growth? - RTTNews
Optimizerx Corp (OPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.28%
1.24%
자본화:
|
볼륨(24시간):